A prostate cancer journey affects more than the patient. Behind every diagnosis is a partner, spouse, family member, or caregiver helping navigate the uncertainty, decisions, and day-to-day realities.
Explore more caregiver stories and support resources: https://t.co/fl2iFr07QX
Mental health is an important part of the prostate cancer journey.
This month, we’re sharing stories, support, and resources focused on the emotional side of diagnosis - because stress and uncertainty deserve attention too.
https://t.co/uqLYLX1PK5
#MentalHealthAwarenessMonth
Prostate cancer does not affect all men equally. In this series, three black men share their experiences with diagnosis, treatment, and advocacy, highlighting the importance of awareness, early detection, and community.
🔗 Explore more patient stories on https://t.co/ZfU9NBJGFI
If you or someone you love is navigating prostate cancer, the right information can make all the difference.
Subscribe to the PCPV newsletter for real patient stories, expert insights, and conversations.
Visit the link in our bio or sign up at https://t.co/oCVhwsLk1b
Not all prostate cancers are the same - and understanding those differences matters.
What is the Decipher Test? https://t.co/XbPgbWwbtj
Understanding your Decipher Report. https://t.co/SPRjtXj682
Questions to Ask about Decipher Testing. https://t.co/mzLyt9Dmht
Veterans face a higher risk of prostate cancer, making targeted research and support essential. During Military Appreciation Month, learn how PCF is advancing care for those who have served: https://t.co/XBZGtYiRUs
February is Black History Month. Black men face a higher risk of prostate cancer, but early detection can save lives. With a 99% cure rate when caught early, a PSA blood test can make the difference. Visit https://t.co/f9DlTMIXlh to learn more. #BlackHistoryMonth#ProstateCancer
PSA (prostate-specific antigen) is a protein produced by the prostate, and very small amounts are found in the bloodstream. It is used as a disease marker to check for prostate cancer.
Ask your doctor about prostate cancer screening.
During #MinorityHealthMonth, we’re raising awareness about the higher risk of prostate cancer among Black men. 1 in 8 men will be diagnosed, but for Black men it's 1 in 6.
Help #AdvancingCommitments for all men facing prostate cancer.
https://t.co/UuaAPVIHix
#MedX#MedEd
A prostate cancer diagnosis can bring very difficult emotions, and hormone therapy can affect mood and thinking. People need to know they are not alone.
Join our March webinar with a mental health focus for those diagnosed with prostate cancer.
https://t.co/lEdr9eYXRh
#MedX
After prostate cancer recurrence, precision matters.
📽️ Hear from 3 patients who used PSMA PET imaging to get clearer insights & targeted treatment options—helping them make the best choices for their care.
Watch Now: https://t.co/GthOi9Lw1C
#prostatecancer#PSMAPET#recurrence
Tomorrow, join @SamWashUro from @UCSFhealth, Leanne Woods-Burnham from @MSMEDU and @sokolova_md from @OHSUNews for our free webinar on understanding your risk for prostate cancer.
🗓️ February 20
⏰ 4PM PT / 7PM ET
RSVP: https://t.co/UAoaK1CKqK
This week’s @ASCO#GU25 Symposium will premiere groundbreaking research and gather medical, research and patient communities to discuss important topics in #prostatecancer.
We are proud of the impact that we are able to make by supporting important #cancerresearch.
#MedEd
This #WorldCancerDay, let’s change the conversation about prostate cancer.
Too many men feel alone after diagnosis, but real stories bring real support.
We are committed to sharing stories & resources to empower men. Early PSA screening is key!
#KnowYourRisk#prostatecancer
A clearer path to treatment:
The Decipher test helped Dr. Arnold Bullock make a critical decision about his prostate cancer care by identifying risks that other tests missed.
Watch his story here: https://t.co/ZepmoGYTvW
#ProstateCancerAwareness#DecipherTesting
✨A Month to Honor Caregivers✨
Prostate cancer impacts more than just patients—it affects everyone who loves them. Caregivers are the unseen heroes, offering strength & care.
💙 Discover inspiring stories and resources for caregivers & patients.💙
https://t.co/I0MDcyf1mi
2024 Key Updates to the @NCCN Prostate Cancer Treatment Guidelines. Key changes in #mCRPC:
✅ Pembrolizumab for MSI-high/DMM/R tumors
✅ Olaparib & rucaparib preferred for BRCA mutations
✅ ARPI switching no longer recommended
Learn more on @Urotoday: https://t.co/vBl6ohH5T4